HOME >> BIOLOGY >> NEWS
Unusual antibiotics show promise against deadly 'superbugs'

WASHINGTON, Aug. 29 An unusual type of antibiotic being developed by chemists at University of Notre Dame shows promise in defeating deadly "superbugs" highly drug-resistant staph bacteria that are an increasing source of hospital-based infections. The novel antibiotics, which could some day save lives, were described today at the 230th national meeting of the American Chemical Society, the worlds largest scientific society.

The new antibiotics are synthetic forms of cephalosporin, a broad-spectrum antibiotic closely related to penicillin. They appear to kill bacteria by masquerading as components of the bacterial cell wall in order to deactivate an enzyme that functions as a key bacterial defense mechanism, the researchers say. In preliminary lab tests, the new antibiotics the first to exhibit this mimicry mechanism were effective against vancomycin-resistant MRSA, a rare but extremely deadly staph strain for which treatment options are extremely limited, they say.

"We are the first to demonstrate this unique strategy, which could provide a new line of defense against the growing problem of antibiotic resistance," says study leader Shahriar Mobashery, Ph.D., a chemist at the university. "As scientists, were trying to stay one step ahead of the bacteria. The more strategies there are to fight resistance, the better."

Besides fighting staph bacteria, the compounds have the potential to work against a wide range of other types of infectious bacterial strains that appear in health-care and community settings, he says. At least one of the cephalosporin compounds identified has entered Phase I clinical trials (human studies), but results are not yet available. More studies are needed before it can be marketed, Mobashery and his associates say.

MRSA (methicillin-resistant Staphylococcus aureus) was first identified in the early 1960s and has become a difficult superbug to tame. While searching for strategies to defeat it, Mobasher
'"/>


29-Aug-2005


Page: 1 2 3

Related biology news :

1. Unusual three-drug combo inhibits growth of aggressive tumors
2. Unusual data shed new light on brain and inhibiting behavior
3. Unusual mechanism keeps repair protein accurate
4. Unusual RNAs linked to chronic leukemia, may help treat it
5. Unusual reproductive behavior of odd ants surprises scientists
6. Researchers watch antibiotics, bacteria meet at atomic level
7. UBC researchers find new superbug weapon for near-empty antibiotics arsenal
8. Will the plague pathogen become resistant to antibiotics?
9. Natural antibiotics yield secrets to atom-level imaging technique
10. Compounds in cranberry juice show promise as alternatives to antibiotics
11. Protein clue to tailor-made antibiotics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... (PRWEB) , ... August 30, 2018 , ... CallTower ... Success. Jason has more than 20-years of telecommunications experience and over ten years in ... Communications, which was acquired by CallTower in early 2018. , In this new ...
(Date:8/31/2018)... ... August 30, 2018 , ... USDM Life Sciences , ... sciences and healthcare industries, has received the 2018 Services Partner of the Year, Awarded ... by Box SVP of Business Development and Platform Sales, Niall Wall and received by ...
(Date:8/29/2018)... Calif. (PRWEB) , ... August ... ... Dx”), a radiopharmaceutical company unlocking the full power of positron emission tomography ... alkali metal catalysis, Fuzionaire Dx is helping clinicians and researchers study and ...
Breaking Biology News(10 mins):
(Date:9/7/2018)... ... September 06, 2018 , ... ... 25th-28th is a meeting of “The industry’s preeminent event on novel drug targets.” ... scientists powerful tools to study these emerging targets in a quest to find ...
(Date:8/31/2018)... ... August 29, 2018 , ... A ... University of Southampton and the Institute of Industrial Science, the University of Tokyo, ... dramatically accelerate the exploration and study of hard to reach deep sea ecosystems, ...
(Date:8/29/2018)... ... August 28, 2018 , ... CEO and founder ... safety study performed on an allogeneic (donor derived) stem cell product for osteoarthritis ... conference in September. He is also the organizer of Breakout Session 4: ...
(Date:8/23/2018)... ... August 22, 2018 , ... Crucial Data Solutions, Inc. ... it the first fully-featured app for electronic data capture (EDC) and electronic participant ... constitute 99 percent of the market share for mobile devices worldwide; in turn, ...
Breaking Biology Technology:
Cached News: